Skip to main content
. 2014 Jan 28;20(4):943–956. doi: 10.3748/wjg.v20.i4.943

Figure 2.

Figure 2

Sources of epigenetic biomarkers of colorectal cancer. Blood and fecal DNA samples represent available non-invasive sources of epigenetic diagnostic biomarkers of colorectal cancer, such as the analysis of methylation of septin 9 (SEPT9) and vimentin (VIM) genes, respectively. In addition, the analysis of DNA samples from bioptic tumor tissues could be of relevance for the best choice of therapeutic intervention.